- recruiting
Metagenomics for Ocular Inflammation
This study uses a special test called 'metagenomic sequencing' to find hidden infections in people with eye inflammation. Current tests often miss these. By finding the infection, doctors hope to offer better, more targeted treatments and improve our understanding of this condition.
United Kingdom - recruiting
PANDA-ASOCT: Paediatric Anterior Uveitis Detection With Automated Image Analysis Using ASOCT
This study looks at a new, quick eye scan for children with uveitis, an eye inflammation. We want to see if this gentle scan can find and track the condition as well as, or better than, the usual eye check. This could help doctors spot and treat uveitis sooner to protect children's sight.
United Kingdom - active not recruiting
UNICORNS: Uveitis in Childhood Prospective National Cohort Study
This study, UNICORNS, looks at eye inflammation (uveitis) in children. It aims to understand why it happens, how it affects children, and how best to treat it. Doctors will simply collect information during normal check-ups; no changes to your child's care are involved.
United Kingdom - recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
This project is building a secure online registry to collect health information from people with rare inflammatory conditions. The goal is to better understand these diseases, how they affect people, and how different treatments work. Your information could help doctors improve care for others.
Algeria · Australia · Belgium - active not recruitingPHASE3
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
This study is looking into a new medication called brepocitinib for adults with a type of eye inflammation called non-infectious uveitis. It aims to see how well it works and if it's safe to use for managing this condition.
United States · Argentina · Australia - active not recruitingPHASE3
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
This study is looking at a new medicine called baricitinib for children and young people aged 2 to 17 who have a specific eye condition called uveitis. We want to see if it's safe and helps reduce eye inflammation, especially for those who haven't responded well to other treatments.
France · Germany · Italy